Introduction
Background
The fibromatoses represents a wide spectrum of locally infiltrative clinicopathologic processes characterized by the proliferation of generally mature fibroblasts associated with mature collagen. Some of these entities are present at birth or develop in early childhood (eg, juvenile fibromatosis [JF]). Others may appear in adulthood.1
The term plantar fibromatosis (PF) is used for different conditions, as follows: (1) a relatively common plantar equivalent of Dupuytren palmar contracture named Ledderhose disease (LD); (2) a more uncommon plantar superficial fibromatosis that, unlike deep fibromatosis (eg, abdominal, extra-abdominal, and visceral fibromatosis) generally has a less aggressive and recurrent tendency; and (3) an extremely rare, benign cerebriform mesodermal hamartomatous proliferation that, in a plantar location, appears to be a clinicopathologic marker of Proteus syndrome (PS).
Juvenile aponeurotic fibroma (JAF) and aggressive infantile fibromatosis (AIF) can also be considered to be in the plantar fibromatosis group when lesions are present on the sole of the foot.
Pathophysiology
Plantar fibromatosis represents not a single entity, but rather, a heterogeneous group of conditions with the common characteristics of plantar location and histologic features of mature collagen and fibroblasts with no malignant cytologic features.
In Ledderhose disease (described in 1897), as in Dupuytren contracture (DC) (first reported in 1831), repeated trauma, long-term alcohol consumption, chronic liver disease, diabetes, and epilepsy have been reported in association with the development of the lesions in middle-aged or elderly people. Often, patients with Ledderhose disease also have other fibrosing conditions such as Dupuytren contracture, knuckle pads, or induratio penis plastica (ie, Peyronie disease, first reported in 1743 by François de la Peyronie, physician of Louis XV of France). Heredity is also a clear factor in many patients.
Superficial fibromatosis (SF) in a plantar location includes a variety of soft-tissue tumoral proliferations of fibroblasts. However, it has been shown that some forms are not due to fibroblast overgrowth but to myofibroblast proliferation; superficial fibromatosis is more common in children and young adults than in older people.
Cerebriform mesodermic hamartomas on the soles represent a kind of mesodermal nevus and are usually associated with Proteus syndrome. This syndrome was named after the Greek god Proteus, the "Old Man of the Sea" and son of Poseidon who was able to change his shape to protect himself. Proteus syndrome is a complex malformative or asymmetric hypertrophic syndrome associated with multiple cutaneous and musculoskeletal manifestations such as epidermal verrucous nevus, vascular hamartomas, and exophytic cerebriform fibrolipomata and scoliosis, kyphosis, and exostosis, respectively.2 Hamartomatous cerebriform plantar fibromatosis may develop on the soles before other manifestations of Proteus syndrome appear, and it is considered a marker for Proteus syndrome.
Fibromas and desmoid tumors (eg, intestinal polyps, osteomas, soft-tissue tumors, epidermal cysts) are common in Gardner syndrome, which was described in 1950. These tumors often arise over previous surgical scars. By means of direct DNA sequencing, recent studies show that somatic beta-catenin or adenomatous polyposis coli (APC) gene mutations are present in virtually 100% of cases of Gardner syndrome–associated fibromatosis (GAF), as well as most cases of deep fibromatosis (DF). On the other hand, no somatic mutations were identified in beta-catenin or APC genes in superficial fibromatosis. Therefore, the divergent behaviors of superficial fibromatosis in relation to DF and GAF, despite their similar clinical and histologic morphologic features, are based on genetic differences.3
Frequency
United States
Ledderhose disease is relatively common, and plantar contracture develops in approximately 25% of middle-aged or elderly individuals (1 of every 4 with Dupuytren contracture). Superficial plantar fibromatosis (SPF) is uncommon, and the hamartomatous form associated with Proteus syndrome is rare. The exact incidences of superficial plantar fibromatosis and the hamartomatous form associated with Proteus syndrome are unknown.
Mortality/Morbidity
- The different varieties of plantar fibromatosis may be asymptomatic. However, the feeling of a mass in the foot, difficulty fitting in shoes, and pain with weight bearing often affect patients' ability to stand or walk.
- Only aggressive infantile fibromatosis has an invasive course, as does fibrosarcoma; however, it does not metastasize.
- Recurrent forms are not uncommon, although plantar fasciectomy has a relatively reduced rate of recurrence in Ledderhose disease.
Race
- Whites are affected more often than other groups.
Sex
- Ledderhose disease affects men approximately 10 times more often than it affects women.
- Juvenile aponeurotic fibroma is more common in boys than in girls.
- No sex predilection is evident for the other forms of plantar fibromatosis.
Age
- Ledderhose disease is seen in middle-aged and elderly people.
- Superficial plantar fibromatosis and juvenile aponeurotic fibroma are most common in children and youths than in adults.
- The exceptional aggressive infantile fibromatosis begins in an infant's first year of life. The rare hamartomatous variety also develops in infants.
Clinical
History
- Patients with Ledderhose disease are not often aware of their disease because it is usually not painful.
- Likewise, patients with other forms of plantar fibromatosis may not be aware of their disease; however, they may notice difficulty in standing, walking, or wearing shoes when nodules or bumps become big enough.
- Ledderhose disease is typically bilateral and progresses slowly but not indefinitely.
- Superficial plantar fibromatosis may grow gradually, and, in most cases, self-involution occurs. In some cases, superficial plantar fibromatosis lesions enlarge and persist; if excised, they recur iteratively.
- Juvenile aponeurotic fibroma can spontaneously regress or persist. Recurrences after excision are common.
Physical
- Ledderhose disease consists of one or more small, asymptomatic, round or flattened, hard nodules that are generally located on the medial side of the sole. Flexion deformities usually do not occur in opposition to Dupuytren contracture.
- Superficial plantar fibromatosis appears as one or more asymptomatic, bad limited, flat nodules of fibrous consistency and variable size. They are most commonly located on the plantar aspect of the anteromedial portion of the heel pad (see Media File 1).
- Juvenile aponeurotic fibroma may appear as a localized form affecting adults or a diffuse variety observed in children. It is more common in males than in females, and the hard nodules grow slowly and adhere to deep structures (see Media File 2).
- Aggressive infantile fibromatosis is rare and ordinarily begins in the patient's first year of life. It grows rapidly and infiltrates the subcutaneous tissue, aponeurosis, and muscles with an expansive or infiltrative course like a fibrosarcoma. However, metastasis does not occur.
- Hamartomatous plantar fibromatosis lesions look like raised cerebriform soft-to-firm exophytic masses on any plantar area, where they are covered by pink, lightly dark, or normal-colored skin (see Media File 3). They can become large enough to cause disability.
- In patients with Ledderhose disease, the presence of other fibrosing conditions (eg, Dupuytren contracture, knuckle pads, Peyronie disease in men) must be checked.
- In superficial plantar fibromatosis, Gardner syndrome must be ruled out.
- In the presence of cerebriform fibrous exophytic plantar lesions, Proteus syndrome must be considered.
Causes
As with many tumors, the causes are not known.
More on Plantar Fibromatosis |
Overview: Plantar Fibromatosis |
| Differential Diagnoses & Workup: Plantar Fibromatosis |
| Treatment & Medication: Plantar Fibromatosis |
| Follow-up: Plantar Fibromatosis |
| Multimedia: Plantar Fibromatosis |
| References |
| Further Reading |
| Next Page » |
References
McPoil TG, Martin RL, Cornwall MW, Wukich DK, Irrgang JJ, Godges JJ. Heel pain--plantar fasciitis: clinical practice guildelines linked to the international classification of function, disability, and health from the orthopaedic section of the American Physical Therapy Association. J Orthop Sports Phys Ther. Apr 2008;38(4):A1-A18. [Medline].
Wiedemann HR, Burgio GR, Aldenhoff P, Kunze J, Kaufmann HJ, Schirg E. The proteus syndrome. Partial gigantism of the hands and/or feet, nevi, hemihypertrophy, subcutaneous tumors, macrocephaly or other skull anomalies and possible accelerated growth and visceral affections. Eur J Pediatr. Mar 1983;140(1):5-12. [Medline].
Montgomery E, Lee JH, Abraham SC, Wu TT. Superficial fibromatoses are genetically distinct from deep fibromatoses. Mod Pathol. Jul 2001;14(7):695-701. [Medline].
Morrison WB, Schweitzer ME, Wapner KL, Lackman RD. Plantar fibromatosis: a benign aggressive neoplasm with a characteristic appearance on MR images. Radiology. Dec 1994;193(3):841-5. [Medline].
Bancroft LW, Peterson JJ, Kransdorf MJ. Imaging of soft tissue lesions of the foot and ankle. Radiol Clin North Am. Nov 2008;46(6):1093-103, vii. [Medline].
Scheler J, Rehani B, Percy T, et al. Increased F-18 FDG uptake on positron emission tomography/computed tomography imaging caused by plantar fibromatosis. Clin Nucl Med. Apr 2008;33(4):280-1. [Medline].
Alman BA, Naber SP, Terek RM, Jiranek WA, Goldberg MJ, Wolfe HJ. Platelet-derived growth factor in fibrous musculoskeletal disorders: a study of pathologic tissue sections and in vitro primary cell cultures. J Orthop Res. Jan 1995;13(1):67-77. [Medline].
DeBrule MB, Mott RC, Funk C, Nixon BP, Armstrong DG. Osseous metaplasia in plantar fibromatosis: a case report. J Foot Ankle Surg. Nov-Dec 2004;43(6):430-2. [Medline].
Evans HL. Multinucleated giant cells in plantar fibromatosis. Am J Surg Pathol. Feb 2002;26(2):244-8. [Medline].
van der Veer WM, Hamburg SM, de Gast A, Niessen FB. Recurrence of plantar fibromatosis after plantar fasciectomy: single-center long-term results. Plast Reconstr Surg. Aug 2008;122(2):486-91. [Medline].
Wapner KL, Ververeli PA, Moore JH Jr, Hecht PJ, Becker CE, Lackman RD. Plantar fibromatosis: a review of primary and recurrent surgical treatment. Foot Ankle Int. Sep 1995;16(9):548-51. [Medline].
[Guideline] American College of Radiology. ACR Appropriateness Criteria chronic foot pain. American College of Radiology. 2005.
[Guideline] American College of Occupational and Environmental Medicine. Ankle and foot complaints. American College of Occupational and Environmental Medicine. 2004.
Allen PW. The Fibromatoses: A clinicopathological classification based in 140 cases. Am J Surg Path. 1977;1:305-21.
Allen RA, Woolner LB, Ghormley RK. Soft-tissue tumors of the sole; with special reference to plantar fibromatosis. J Bone Joint Surg Am. Jan 1955;37-A(1):14-26. [Medline].
Durr HR, Krodel A, Trouillier H, Lienemann A, Refior HJ. Fibromatosis of the plantar fascia: diagnosis and indications for surgical treatment. Foot Ankle Int. Jan 1999;20(1):13-7. [Medline].
Enzinger FM, Weiss SW. Fibrous proliferations of infancy and childhood. In: Soft Tissue Tumors. St Louis: Mosby; 1983.
Fetsch JF, Laskin WB, Miettinen M. Palmar-plantar fibromatosis in children and preadolescents: a clinicopathologic study of 56 cases with newly recognized demographics and extended follow-up information. Am J Surg Pathol. Aug 2005;29(8):1095-105. [Medline].
Godette GA, O'Sullivan M, Menelaus MB. Plantar fibromatosis of the heel in children: a report of 14 cases. J Pediatr Orthop. Jan-Feb 1997;17(1):16-7. [Medline].
Mascaro JM, Torres V. Juvenile fibromatosis. Proceedings XV World Congress of Dermatology in Mexico. 1976;63-6.
Pickren JW, Smith AG, Stevenson TW. Fibromatosis of the plantar fascia. Cancer. 1951;4:846.
Sammarco GJ, Mangone PG. Classification and treatment of plantar fibromatosis. Foot Ankle Int. Jul 2000;21(7):563-9. [Medline].
Shapiro L. Infantile digital fibromatosis and aponeurotic fibroma. Case reports of tow rare pseudosarcomas and review of the literature. Arch Dermatol. Jan 1969;99(1):37-42. [Medline].
Further Reading
Clinical guidelines
ACR Appropriateness Criteria® chronic foot pain. 12
American College of Radiology - Medical Specialty Society. 1998 (revised 2005). 7 pages. NGC:004618
Ankle and foot complaints. 13
American College of Occupational and Environmental Medicine - Medical Specialty Society. 1997 (revised 2004). 27 pages. NGC:004757
Clinical trials
Health-Related Quality of Life in Patients With Dupuytren's Disease
Effects of Steroid Injection With Percutaneous Needle Aponeurotomy in Dupuytren's Contracture
Study of Proteus Syndrome and Related Congenital Disorders
Related eMedicine topics
Dupuytren Contracture (Dermatology)
Dupuytren Contracture (Orthopedic Surgery)
Dupuytren Contracture (Physical Medicine and Rehabilitation)
Plantar Heel Pain
Skin Malignancies, Merkel Cell Carcinoma and Rare Appendageal Tumors
Keywords
plantar fibromatosis, PF, juvenile fibromatosis, JF, Dupuytren palmar contracture, DC, Ledderhose disease, LD, juvenile aponeurotic fibroma, JAF, infantile fibromatosis, aggressive infantile fibromatosis, AIF, superficial fibromatosis, SF, cerebriform mesodermic hamartomas, Proteus syndrome, PS, fibromas, desmoid tumors, Gardner syndrome, GAF, Gardner syndrome–associated fibromatosis, deep fibromatosis, DF, hamartomatous fibromatosis






Overview: Plantar Fibromatosis